Publicaciones Imprimir Neuman HB, Kwekkeboom KL, Tevaarwerk AJ, Phelps K, Tucholka JL, Maxcy C, Breuer CR, Schumacher JR. Engaging survivor and oncologist stakeholders to develop a patient-reported outcome assessment to use as a component of survivorship care. Support Care Cancer. 2024 Dec 9; 33 (1):9 Epub 2024 Dec 09 View PubMed Sanft T, Day AT, Goldman M, Ansbaugh S, Armenian S, Baker KS, Ballinger TJ, Demark-Wahnefried W, Fairman NP, Feliciano J, Flores TF, Friedman DL, Gabel N, Hill-Kayser C, Koura D, Lee K, Lee N, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, Overholser L, Patel C, Peterson L, Pirl W, Porpiglia A, Schapira L, Schwartz A, Smith S, Tevaarwerk A, Von Ah D, Wake R, Yang E, Zee P, McMillian N, Freedman-Cass D. NCCN Guidelines(R) Insights: Survivorship, Version 2.2024. J Natl Compr Canc Netw. 2024 Dec; 22 (10):648-658 View PubMed Jahan N, Taraba J, Boddicker NJ, Giridhar KV, Leon-Ferre RA, Tevaarwerk AJ, Cathcart-Rake E, O'Sullivan CC, Peethambaram PP, Hobday TJ, Mina LA, Batalini F, Advani P, Sideras K, Haddad TC, Ruddy KJ, Goetz MP, Couch FJ, Yadav S. Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clin Breast Cancer. 2024 Oct 17 [Epub ahead of print] View PubMed Cathcart-Rake EJ, Tevaarwerk A, Jatoi A, Carroll EF, Scout N, Chedid VG, Gonzalez CA, Fee-Schroeder K, Kling JM, Shufelt CL, Ridgeway JL, Davidge-Pitts C. Building a Cancer Care Clinic for Transgender and Gender Diverse Individuals. Mayo Clin Proc Innov Qual Outcomes. 2024 Oct; 8 (5):443-450 Epub 2024 Aug 22 View PubMed Khan MA, Ayub U, Naqvi SAA, Khakwani KZR, Sipra ZBR, Raina A, Zou S, He H, Hossein SA, Hasan B, Rumble RB, Bitterman DS, Warner JL, Zou J, Tevaarwerk AJ, Leventakos K, Kehl KL, Palmer JM, Murad MH, Baral C, Riaz IB. Collaborative Large Language Models for Automated Data Extraction in Living Systematic Reviews. medRxiv. 2024 Sep 23 Epub 2024 Sept 23 View PubMed Carroll CB, Tevaarwerk AJ, Henningfield MF, Yuroff AS, Bolan C, Geiger K, Ward EC, Schrager S. Identifying Local Facilitators and Barriers to Screening Mammography Within a Rural Acute Care Hospital Service Area. WMJ. 2024 Sep; 123 (4):259-266 View PubMed Smith KL, Zhao F, Mayer IA, Tevaarwerk AJ, Garcia SF, Arteaga CL, Symmans WF, Park BH, Burnette BL, Makower DF, Block M, Morley KA, Jani CR, Mescher C, Dewani SJ, Brown-Glaberman U, Flaum LE, Mayer EL, Sikov WM, Rodler ET, DeMichele AM, Sparano JA, Wolff AC, Miller KD, Wagner LI. Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131. Cancer. 2024 May 15; 130 (10):1747-1757 Epub 2024 Jan 18 View PubMed Tevaarwerk AJ, Karam D, Gatten CA, Harlos ES, Maurer MJ, Giridhar KV, Haddad TC, Alberts SR, Holton SJ, Stockham A, Leventakos K, Hubbard JM, Mansfield AS, Halfdanarson TR, Chen R, Jochum JA, Schwecke AS, Eiring RA, Carroll JL, Riaz IB, McWilliams RR, Galanis E, Mandrekar SJ. Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot. Cancer. 2024 Apr 25 [Epub ahead of print] View PubMed Cathcart-Rake EJ, Ruddy KJ, Tevaarwerk AJ, Jatoi A. Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals. Maturitas. 2024 Mar; 181:107913 Epub 2024 Jan 17 View PubMed Lawler T, Warren Andersen S, Trentham-Dietz A, Sethi AK, Tevaarwerk AJ, Malecki KMC, Litzelman K, Pophali PA, Gangnon RE, Hampton JM, Kwekkeboom K, LoConte NK. Change in alcohol consumption during the Covid-19 pandemic and associations with mental health and financial hardship: results from a survey of Wisconsin patients with cancer. J Cancer Surviv. 2023 Nov 28 [Epub ahead of print] View PubMed Cathcart-Rake EJ, Tevaarwerk AJ, Haddad TC, D'Andre SD, Ruddy KJ. Advances in the care of breast cancer survivors. BMJ. 2023 Sep 18; 382:e071565 Epub 2023 Sept 18 View PubMed Arafat W, Fu P Jr, Wagner AJ, Osterman T, Martin DB, Sugalski J, Heinrichs T, Racz J, Tevaarwerk AJ. Clinician Perspectives Regarding the Impact of Information Technology on Multidisciplinary Tumor Boards: A National Comprehensive Cancer Network Survey. JCO Clin Cancer Inform. 2023 Sep; 7:e2300056 View PubMed Cracchiolo JR, Arafat W, Atreja A, Bruckner L, Emamekhoo H, Heinrichs T, Raldow AC, Smerage J, Stetson P, Sugalski J, Tevaarwerk AJ. Getting ready for real-world use of electronic patient-reported outcomes (ePROs) for patients with cancer: A National Comprehensive Cancer Network ePRO Workgroup paper. Cancer. 2023 Aug 15; 129 (16):2441-2449 Epub 2023 May 24 View PubMed Sanft T, Day A, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Demark-Wahnefried W, Dickinson K, Fairman NP, Felciano J, Flores TF, Friedman DL, Gabel NM, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Koura D, Lee K, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Peterson L, Pirl W, Porpiglia A, Rodriguez MA, Schapira L, Schwartz AL, Smith S, Tevaarwerk A, Yang E, Zee P, McMillian NR, Freedman-Cass DA. NCCN Guidelines(R) Insights: Survivorship, Version 1.2023. J Natl Compr Canc Netw. 2023 Aug; 21 (8):792-803 View PubMed Cadmus-Bertram L, Solk P, Agnew M, Starikovsky J, Schmidt C, Morelli WA, Hodgson V, Freeman H, Muller L, Mishory A, Naxi S, Carden L, Tevaarwerk AJ, Wolter M, Barber E, Spencer R, Sesto ME, Gradishar W, Gangnon R, Spring B, Nahum-Shani I, Phillips SM. A multi-site trial of an electronic health integrated physical activity promotion intervention in breast and endometrial cancers survivors: MyActivity study protocol. Contemp Clin Trials. 2023 Jul; 130:107187 Epub 2023 Apr 21 View PubMed Farooque A, Osman F, Carroll CB, Ewer S, Lee-Miller C, Tevaarwerk A, Pophali PA. Pre-Treatment Left Ventricular Ejection Fraction Assessment and Long-Term Cardiovascular Outcomes in Adolescent and Young Adult Lymphoma Survivors. J Adolesc Young Adult Oncol. 2023 Jun; 12 (3):331-339 Epub 2022 Sept 02 View PubMed Kochan DC, Novotny PJ, Cathcart-Rake EJ, Orme JJ, Tevaarwerk AJ, Ruddy KJ, Childs DS. An evaluation of the effect of lithium on taxane-induced neuropathy. Support Care Cancer. 2023 Apr 25; 31(5):299. View PubMed Emamekhoo H, Chandereng T, Sesto ME, Luoh R, Bergeson EM, Barbosa Carroll C, Tevaarwerk AJ. Patterns of Health Portal Use by Regular Portal Users Among Patients With Cancer: Results From the UWCCC Survivorship Program. JCO Clin Cancer Inform. 2023 Jan; 7:e2200119 View PubMed Hsiao V, Chandereng T, Huebner JA, Kunstman DT, Flood GE, Tevaarwerk AJ, Schneider DF. Telemedicine Use across Medical Specialties and Diagnoses. Appl Clin Inform. 2023 Jan; 14 (1):172-184 Epub 2023 Mar 01 View PubMed Sanft T, Day A, Peterson L, Rodriguez MA, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Broderick G, Demark-Wahnefried W, Dickinson K, Fairman NP, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Pirl W, Porpiglia A, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Yang EH, Zee P, McMillian NR, Freedman-Cass DA. NCCN Guidelines® Insights: Survivorship, Version 1.2022. J Natl Compr Canc Netw. 2022 Oct; 20(10):1080-1090. View PubMed Emamekhoo H, Carroll CB, Stietz C, Pier JB, Lavitschke MD, Mulkerin D, Sesto ME, Tevaarwerk AJ. Supporting Structured Data Capture for Patients With Cancer: An Initiative of the University of Wisconsin Carbone Cancer Center Survivorship Program to Improve Capture of Malignant Diagnosis and Cancer Staging Data. JCO Clin Cancer Inform. 2022 Jun; 6:e2200020 View PubMed Khan SA, Zhao F, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, Pockaj BA, Lee CA, Razaq W, Sparano JA, Babiera GV, Dy IA, Jain S, Silverman P, Fisher CS, Tevaarwerk AJ, Wagner LI, Sledge GW. Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108). J Clin Oncol. 2022 Mar 20; 40 (9):978-987 Epub 2022 Jan 07 View PubMed Garcia SF, Gray RJ, Sparano JA, Tevaarwerk AJ, Carlos RC, Yanez B, Gareen IF, Whelan TJ, Sledge GW, Cella D, Wagner LI. Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy. Cancer. 2022 Feb 1; 128 (3):536-546 Epub 2021 Oct 06 View PubMed Stewart TP, Sesto ME, Haine JE, Henningfield MF, Norslien K, Zhang X, Hahn DL, Tevaarwerk AJ. Results of Engineering, Primary Care, Oncology Collaborative Regarding a Survey of Primary Care on a Re-Engineered Survivorship Care Plan. J Cancer Educ. 2022 Feb; 37 (1):23-29 View PubMed Morken C, Tevaarwerk AJ, Juckett MB, Swiecichowski AK, Haine JE, Zhang X, Williams ZT, Norslien K, Campbell B, Wassenaar T, Sesto ME. Barriers and facilitators to the use of survivorship care plans by hematopoietic stem cell transplant survivors and clinicians. Support Care Cancer. 2022 Feb; 30 (2):1323-1330 Epub 2021 Sept 05 View PubMed Stetson PD, McCleary NJ, Osterman T, Ramchandran K, Tevaarwerk A, Wong T, Sugalski JM, Akerley W, Mercurio A, Zachariah FJ, Yamzon J, Stillman RC, Gabriel PE, Heinrichs T, Kerrigan K, Patel SB, Gilbert SM, Weiss E. Adoption of Patient-Generated Health Data in Oncology: A Report From the NCCN EHR Oncology Advisory Group. J Natl Compr Canc Netw. 2022 Jan 18; 1-6 [Epub ahead of print] View PubMed Sanft T, Day A, Peterson L, Rodriguez MA, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Broderick G, Demark-Wahnefried W, Dickinson K, Fairman NP, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, Overholser L, Paskett ED, Patel C, Pirl W, Porpiglia A, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Yang EH, Zee P, McMillian NR, Freedman-Cass DA. Survivorship, version 1.2022: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network: JNCCN. 2022; 20 (10):1080-90 Hu Y, Manasrah BK, McGregor SM, Lera RF, Norman RX, Tucker JB, Scribano CM, Yan RE, Humayun M, Wisinski KB, Tevaarwerk AJ, O'Regan RM, Wilke LG, Weaver BA, Beebe DJ, Jin N, Burkard ME. Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer. Mol Cancer Ther. 2021 Dec; 20 (12):2553-2567 Epub 2021 Sept 28 View PubMed Cull Weatherer AL, Krebsbach JK, Tevaarwerk AJ, Kerch SC, LoConte NK. The current status of survivorship care provision at the state level: a Wisconsin-based assessment. J Cancer Surviv. 2021 Oct 5 Epub 2021 Oct 05 View PubMed Luoh RP, Tevaarwerk AJ, Chandereng T, Smith EM, Carroll CB, Emamekhoo H, Sesto ME. Patterns and predictors of cancer-specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship Program. Cancer Med. 2021 Oct; 10 (20):7373-7382 Epub 2021 Aug 28 View PubMed Scribano CM, Wan J, Esbona K, Tucker JB, Lasek A, Zhou AS, Zasadil LM, Molini R, Fitzgerald J, Lager AM, Laffin JJ, Correia-Staudt K, Wisinski KB, Tevaarwerk AJ, O'Regan R, McGregor SM, Fowler AM, Chappell RJ, Bugni TS, Burkard ME, Weaver BA. Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel. Sci Transl Med. 2021 Sep 8; 13 (610):eabd4811 Epub 2021 Sept 08 View PubMed Chen KB, Yen T, Sun W, Tevaarwerk AJ, Wiegmann DA, Heidrich SM, Sesto ME. Usage of a Web-Based Workplace and Symptom Self-Management Intervention Tool to Improve Work Ability for Breast Cancer Survivors. J Cancer Educ. 2021 Sep 3 Epub 2021 Sept 03 View PubMed Tevaarwerk AJ, Chandereng T, Osterman T, Arafat W, Smerage J, Polubriaginof FCG, Heinrichs T, Sugalski J, Martin DB. Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey. JCO Oncol Pract. 2021 Sep; 17 (9):e1318-e1326 Epub 2021 July 15 View PubMed Mayer IA, Zhao F, Arteaga CL, Symmans WF, Park BH, Burnette BL, Tevaarwerk AJ, Garcia SF, Smith KL, Makower DF, Block M, Morley KA, Jani CR, Mescher C, Dewani SJ, Tawfik B, Flaum LE, Mayer EL, Sikov WM, Rodler ET, Wagner LI, DeMichele AM, Sparano JA, Wolff AC, Miller KD. Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131. J Clin Oncol. 2021 Aug 10; 39 (23):2539-2551 Epub 2021 June 06 View PubMed Tevaarwerk A, Denlinger CS, Sanft T, Ansbaugh SM, Armenian S, Baker KS, Broderick G, Day A, Demark-Wahnefried W, Dickinson K, Friedman DL, Ganz P, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Patel C, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Zee P, McMillian NR, Freedman-Cass DA. Survivorship, Version 1.2021. J Natl Compr Canc Netw. 2021 Jun 30; 19(6):676-685. View PubMed Hsiao V, Chandereng T, Lankton RL, Huebner JA, Baltus JJ, Flood GE, Dean SM, Tevaarwerk AJ, Schneider DF. Disparities in Telemedicine Access: A Cross-Sectional Study of a Newly Established Infrastructure during the COVID-19 Pandemic. Appl Clin Inform. 2021 May; 12 (3):445-458 Epub 2021 June 09 View PubMed Cha L, Tevaarwerk AJ, Smith EM, Chandereng T, Huenerberg KJ, Seaborne LA, Carroll CB, Sesto ME. Reported Concerns and Acceptance of Information or Referrals Among Breast Cancer Survivors Seen for Care Planning Visits: Results from the University of Wisconsin Carbone Cancer Center Survivorship Program. J Cancer Educ. 2021 Apr 26 [Epub ahead of print] View PubMed Tevaarwerk AJ, Zhang X, Haine J, Norslien K, Henningfield MF, Stietz C, Hahn D, Sesto ME. Re-engineering Survivorship Care Plans to Support Primary Care Needs and Workflow: Results From an Engineering, Primary Care and Oncology Collaborative for Survivorship Health (EPOCH). J Cancer Educ. 2021 Apr 26 [Epub ahead of print] View PubMed Tevaarwerk AJ, Kwekkeboom K, Buhr KA, Dennee A, Conkright W, Onitilo AA, Robinson E, Ahuja H, Kwong RW, Nanad R, Wiegmann DA, Chen K, LoConte NK, Wisinski KB, Sesto ME. Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study. Cancer. 2021 Mar 1; 127 (5):801-808 Epub 2020 Nov 24 View PubMed Strigel RM, Bravo E, Tevaarwerk AJ, Anderson BM, Stella AL, Neuman HB. Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer. Clin Breast Cancer. 2021 Feb; 21 (1):26-30 Epub 2020 Oct 17 View PubMed Antony KM, Adams JH, Jacques L, Hetzel S, Chappell RJ, Gnadt SE, Tevaarwerk AJ. Lidocaine patches for postcesarean pain control in obese women: a pilot randomized controlled trial. Am J Obstet Gynecol MFM. 2021 Jan; 3 (1):100281 Epub 2020 Nov 26 View PubMed Rastogi S, Tevaarwerk AJ, Sesto M, Van Remortel B, Date P, Gangnon R, Thraen-Borowski K, Cadmus-Bertram L. Effect of a technology-supported physical activity intervention on health-related quality of life, sleep, and processes of behavior change in cancer survivors: A randomized controlled trial. Psychooncology. 2020 Nov; 29 (11):1917-1926 Epub 2020 Oct 04 View PubMed Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, O'Connor T, Paskett ED, Patel C, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Zee P, McMillian NR, Freedman-Cass DA. NCCN Guidelines Insights: Survivorship, Version 2.2020. J Natl Compr Canc Netw. 2020 Aug; 18 (8):1016-1023 View PubMed Wagner LI, Gray RJ, Sparano JA, Whelan TJ, Garcia SF, Yanez B, Tevaarwerk AJ, Carlos RC, Albain KS, Olson JA Jr, Goetz MP, Pritchard KI, Hayes DF, Geyer CE, Dees EC, McCaskill-Stevens WJ, Minasian LM, Sledge GW Jr, Cella D. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. J Clin Oncol. 2020 Jun 10; 38 (17):1875-1886 Epub 2020 Apr 09 View PubMed Hua A, Sesto ME, Zhang X, Wassenaar TR, Tevaarwerk AJ. Impact of Survivorship Care Plans and Planning on Breast, Colon, and Prostate Cancer Survivors in a Community Oncology Practice. J Cancer Educ. 2020 Apr; 35 (2):249-255 View PubMed Kumar M, Salem K, Tevaarwerk AJ, Strigel RM, Fowler AM. Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer. J Nucl Med. 2020 Feb; 61 (2):172-176 Epub 2019 Nov 15 View PubMed Cadmus-Bertram L, Tevaarwerk AJ, Sesto ME, Gangnon R, Van Remortel B, Date P. Building a physical activity intervention into clinical care for breast and colorectal cancer survivors in Wisconsin: a randomized controlled pilot trial. J Cancer Surviv. 2019 Aug; 13 (4):593-602 Epub 2019 July 01 View PubMed Sanft T, Denlinger CS, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Mooney K, Moore HCF, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Zee P, McMillian NR, Freedman-Cass DA. NCCN Guidelines Insights: Survivorship, Version 2.2019. J Natl Compr Canc Netw. 2019 Jul 1; 17 (7):784-794 View PubMed Morken CM, Tevaarwerk AJ, Swiecichowski AK, Haine JE, Williams ZT, Norslien K, Arroyo N, Zhang X, Campbell B, Mendonca EA, Juckett MB, Sesto ME. Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health. Biol Blood Marrow Transplant. 2019 Jun; 25(6):1240-1246. Epub 2019 Feb 11. View PubMed Donohue S, Haine JE, Li Z, Feldstein DA, Micek M, Trowbridge ER, Kamnetz SA, Sosman JM, Wilke LG, Sesto ME, Tevaarwerk AJ. Cancer Survivorship Care Plan Utilization and Impact on Clinical Decision-Making at Point-of-Care Visits with Primary Care: Results from an Engineering, Primary Care, and Oncology Collaborative for Survivorship Health. J Cancer Educ. 2019 Apr; 34 (2):252-258 View PubMed Tevaarwerk AJ, Hocking WG, Buhr KA, Gribble M, Seaborne LA, Wisinski KB, Burkard ME, Yen T, Wiegmann DA, Sesto ME. A randomized trial of immediate versus delayed survivorship care plan receipt on patient satisfaction and knowledge of diagnosis and treatment. Cancer. 2019 Mar 15; 125 (6):1000-1007 Epub 2019 Jan 28 View PubMed Donohue S, Haine JE, Li Z, Trowbridge ER, Kamnetz SA, Feldstein DA, Sosman JM, Wilke LG, Sesto ME, Tevaarwerk AJ. The Impact of a Primary Care Education Program Regarding Cancer Survivorship Care Plans: Results from an Engineering, Primary Care, and Oncology Collaborative for Survivorship Health. J Cancer Educ. 2019 Feb; 34 (1):154-160 View PubMed Tevaarwerk AJ, Klemp JR, van Londen GJ, Hesse BW, Sesto ME. Moving beyond static survivorship care plans: A systems engineering approach to population health management for cancer survivors. Cancer. 2018 Nov 15; 124 (22):4292-4300 Epub 2018 Sept 12 View PubMed Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Oct; 16(10):1216-1247. View PubMed Tevaarwerk AJ, Sesto ME. Continued Challenges to the Adoption and Implementation of Survivorship Care Plans. J Oncol Pract. 2018 Oct; 14 (10):573-576 Epub 2018 Sept 07 View PubMed Miller KD, O'Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Dang CT, Sledge GW Jr. Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103). J Clin Oncol. 2018 Sep 1; 36 (25):2621-2629 Epub 2018 July 24 View PubMed Tucholka JL, Jacobson N, Steffens NM, Schumacher JR, Tevaarwerk AJ, Anderson B, Wilke LG, Greenberg CC, Neuman HB. Breast cancer survivor's perspectives on the role different providers play in follow-up care. Support Care Cancer. 2018 Jun; 26 (6):2015-2022 Epub 2018 Jan 13 View PubMed Litzelman K, Keller AO, Tevaarwerk A, DuBenske L. Adequacy of Depression Treatment in Spouses of Cancer Survivors: Findings From a Nationally Representative US Survey. J Gen Intern Med. 2018 Jun; 33 (6):869-876 Epub 2018 Feb 05 View PubMed Huenerberg KJ, Anderson BM, Tevaarwerk AJ, Neuman HB, Wilke LG, Seaborne LA, Sesto M. Integrating survivorship care planning in radiation oncology workflow. J Community Support Oncol. 2018 Mar-Apr; 16 (2):e66-e71 View PubMed Yeruva SLH, Zhao F, Miller KD, Tevaarwerk AJ, Wagner LI, Gray RJ, Sparano JA, Connolly RM. E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. NPJ Breast Cancer. 2018; 4:1 Epub 2018 Jan 11 View PubMed Ma CX, Suman V, Goetz MP, Northfelt D, Burkard ME, Ademuyiwa F, Naughton M, Margenthaler J, Aft R, Gray R, Tevaarwerk A, Wilke L, Haddad T, Moynihan T, Loprinzi C, Hieken T, Barnell EK, Skidmore ZL, Feng YY, Krysiak K, Hoog J, Guo Z, Nehring L, Wisinski KB, Mardis E, Hagemann IS, Vij K, Sanati S, Al-Kateb H, Griffith OL, Griffith M, Doyle L, Erlichman C, Ellis MJ. A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer. Clin Cancer Res. 2017 Nov 15; 23(22):6823-6832. Epub 2017 Sep 05. View PubMed Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum TS, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, Freedman-Cass DA, McMillian NR. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Sep; 15(9):1140-1163. View PubMed Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum TS, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, Freedman-Cass DA, McMillian NR. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2017 Sep 1; 15 (9):1140-63 Tevaarwerk AJ, Hocking WG, Zeal JL, Gribble M, Seaborne L, Buhr KA, Wisinski KB, Burkard ME, Wiegmann DA, Sesto ME. Accuracy and Thoroughness of Treatment Summaries Provided as Part of Survivorship Care Plans Prepared by Two Cancer Centers. J Oncol Pract. 2017 May; 13 (5):e486-e495 Epub 2017 Feb 21 View PubMed Mirrielees JA, Breckheimer KR, White TA, Denure DA, Schroeder MM, Gaines ME, Wilke LG, Tevaarwerk AJ. Breast Cancer Survivor Advocacy at a University Hospital: Development of a Peer Support Program with Evaluation by Patients, Advocates, and Clinicians. J Cancer Educ. 2017 Mar; 32 (1):97-104 View PubMed Rampurwala M, Wisinski KB, Burkard ME, Ehsani S, O'Regan RM, Carmichael L, Kim K, Kolesar J, Tevaarwerk AJ. Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. Invest New Drugs. 2017 Feb; 35 (1):87-94 Epub 2016 Nov 08 View PubMed Tevaarwerk AJ, Wisinski KB, O'Regan RM. Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer. J Oncol Pract. 2016 Nov; 12 (11):1148-1156 View PubMed Neuman HB, Jacobs EA, Steffens NM, Jacobson N, Tevaarwerk A, Wilke LG, Tucholka J, Greenberg CC. Oncologists' perceived barriers to an expanded role for primary care in breast cancer survivorship care. Cancer Med. 2016 Sep; 5 (9):2198-204 Epub 2016 June 30 View PubMed Wisinski KB, Xu W, Tevaarwerk AJ, Saha S, Kim K, Traynor A, Dietrich L, Hegeman R, Patel D, Blank J, Harter J, Burkard ME. Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study. Clin Breast Cancer. 2016 Aug; 16 (4):256-61 Epub 2016 Mar 31 View PubMed Wisinski KB, Tevaarwerk AJ, Burkard ME, Rampurwala M, Eickhoff J, Bell MC, Kolesar JM, Flynn C, Liu G. Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer. Clin Cancer Res. 2016 Jun 1; 22 (11):2659-67 Epub 2016 Mar 29 View PubMed Tevaarwerk AJ, Lee JW, Terhaar A, Sesto ME, Smith ML, Cleeland CS, Fisch MJ. Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study. Cancer. 2016 Feb 1; 122 (3):438-46 Epub 2015 Dec 21 View PubMed Sun W, Chen K, Terhaar A, Wiegmann DA, Heidrich SM, Tevaarwerk AJ, Sesto ME. Work-related barriers, facilitators, and strategies of breast cancer survivors working during curative treatment. Work. 2016; 55 (4):783-795 View PubMed Wisinski KB, Cantu CA, Eickhoff J, Osterby K, Tevaarwerk AJ, Heideman J, Liu G, Wilding G, Johnston S, Kolesar JM. Potential cytochrome P-450 drug-drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials. Am J Health Syst Pharm. 2015 Jun 1; 72 (11):958-65 View PubMed Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ. Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. J Community Support Oncol. 2015 May; 13 (5):195-201 View PubMed Ehsani S, Strigel RM, Pettke E, Wilke L, Tevaarwerk AJ, DeMartini WB, Wisinski KB. Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer. Breast J. 2015 May-Jun; 21 (3):246-53 Epub 2015 Mar 17 View PubMed Donohue S, Sesto ME, Hahn DL, Buhr KA, Jacobs EA, Sosman JM, Andreason MJ, Wiegmann DA, Tevaarwerk AJ. Evaluating primary care providers' views on survivorship care plans generated by an electronic health record system. J Oncol Pract. 2015 May; 11 (3):e329-35 Epub 2015 Mar 24 View PubMed LoConte NK, Razak AR, Ivy P, Tevaarwerk A, Leverence R, Kolesar J, Siu L, Lubner SJ, Mulkerin DL, Schelman WR, Deming DA, Holen KD, Carmichael L, Eickhoff J, Liu G. A multicenter phase 1 study of gamma -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors. Invest New Drugs. 2015 Feb; 33 (1):169-76 Epub 2014 Oct 17 View PubMed Tevaarwerk AJ, Wang M, Zhao F, Fetting JH, Cella D, Wagner LI, Martino S, Ingle JN, Sparano JA, Solin LJ, Wood WC, Robert NJ. Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2014 Dec 10; 32 (35):3948-58 Epub 2014 Oct 27 View PubMed Burkard ME, Wisinski KB, Njiaju UO, Donohue S, Hegeman R, Stella A, Mansky P, Shah V, Goggins T, Qamar R, Dietrich L, Kim K, Traynor AM, Tevaarwerk AJ. Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study. Clin Breast Cancer. 2014 Jun; 14 (3):205-11 Epub 2013 Oct 26 View PubMed Rocque GB, Wisinski KB, Buhr KA, Froeschner JL, Jones N, Donohue S, Wiegmann D, Sesto ME, Tevaarwerk AJ. Development and evaluation of a survey to assess survivor knowledge change after survivorship care plans: WiSDOM-B (Wisconsin Survey of cancer DiagnOsis and Management in Breast cancer). J Cancer Educ. 2014 Jun; 29 (2):270-7 View PubMed Tevaarwerk AJ, Wisinski KB, Buhr KA, Njiaju UO, Tun M, Donohue S, Sekhon N, Yen T, Wiegmann DA, Sesto ME. Leveraging electronic health record systems to create and provide electronic cancer survivorship care plans: a pilot study. J Oncol Pract. 2014 May; 10 (3):e150-9 Epub 2014 Feb 11 View PubMed Zasadil LM, Andersen KA, Yeum D, Rocque GB, Wilke LG, Tevaarwerk AJ, Raines RT, Burkard ME, Weaver BA. Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med. 2014 Mar 26; 6 (229):229ra43 View PubMed Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch MJ. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv. 2013 Jun; 7 (2):191-202 Epub 2013 Feb 02 View PubMed Tevaarwerk AJ, Gray RJ, Schneider BP, Smith ML, Wagner LI, Fetting JH, Davidson N, Goldstein LJ, Miller KD, Sparano JA. Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years. Cancer. 2013 Mar 15; 119 (6):1140-8 Epub 2012 Oct 12 View PubMed Njiaju UO, Tevaarwerk AJ, Kim K, Chang JE, Hansen RM, Champeny TL, Traynor AM, Meadows S, Van Ummersen L, Powers K, Stewart JA. Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial. Cancer Chemother Pharmacol. 2013 Mar; 71 (3):613-8 Epub 2012 Dec 11 View PubMed Valachis A, Polyzos NP, Coleman RE, Gnant M, Eidtmann H, Brufsky AM, Aft R, Tevaarwerk AJ, Swenson K, Lind P, Mauri D. Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis. Oncologist. 2013; 18 (4):353-61 Epub 2013 Feb 12 View PubMed Sesto ME, Faatin M, Wang S, Tevaarwerk AJ, Wiegmann DA. Employment and retirement status of older cancer survivors compared to non-cancer siblings. Work. 2013; 46 (4):445-53 View PubMed Tevaarwerk A, Burkard ME, Wisinski KB, Shafer MM, Davis LA, Gogineni J, Crone E, Hansen KE. Aromatase inhibitors and calcium absorption in early stage breast cancer. Breast Cancer Res Treat. 2012 Jul; 134 (1):245-51 Epub 2012 Feb 18 View PubMed Tevaarwerk A, Wilding G, Eickhoff J, Chappell R, Sidor C, Arnott J, Bailey H, Schelman W, Liu G. Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design. Invest New Drugs. 2012 Jun; 30 (3):1039-45 Epub 2011 Jan 12 View PubMed Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME. Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. Breast Cancer Res Treat. 2012 Jan; 131 (2):713-21 Epub 2011 Nov 08 View PubMed Lepeak L, Tevaarwerk A, Jones N, Williamson A, Cetnar J, LoConte N. Persistence in breast cancer disparities between African Americans and whites in Wisconsin. WMJ. 2011 Feb; 110 (1):21-5 View PubMed Loconte NK, Williamson A, Gayle A, Weiss J, Leal T, Cetnar J, Mohammed T, Tevaarwerk A, Jones N. Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience. J Gastrointest Oncol. 2011; 2 (2):85-92 View PubMed Leal T, Tevaarwerk A, Love R, Stewart J, Binkley N, Eickhoff J, Parrot B, Mulkerin D. Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer. Clin Breast Cancer. 2010 Dec 1; 10 (6):471-6 View PubMed Attia S, Morgan-Meadows S, Holen KD, Bailey HH, Eickhoff JC, Schelman WR, Traynor AM, Mulkerin DL, Campbell TC, McFarland TA, Huie MS, Cleary JF, Tevaarwerk AJ, Alberti DB, Wilding G, Liu G. Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies. Cancer Chemother Pharmacol. 2009 Jun; 64(1):45-51. Epub 2008 Oct 08. View PubMed Tevaarwerk AJ, Holen KD, Alberti DB, Sidor C, Arnott J, Quon C, Wilding G, Liu G. Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies. Clin Cancer Res. 2009 Feb 15; 15 (4):1460-5 View PubMed Tevaarwerk AJ, Kolesar JM. Lapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer. Clin Ther. 2009; 31 Pt 2:2332-48 View PubMed Kanagawa O, Xu G, Tevaarwerk A, Vaupel BA. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci. J Immunol. 2000 Apr 1; 164 (7):3919-23 View PubMed PST-20527632 Inicio Publicaciones